## Distinguishing Autoimmune Hemolytic Anemia Variants ### Understanding the Correct Answer **Key Point:** Spherocytes in AIHA result from **antibody-mediated opsonization and partial membrane loss**, NOT complement-mediated lysis. Complement-mediated lysis is the mechanism in cold agglutinin disease (CAD), not warm AIHA. ### Pathophysiology of RBC Destruction in AIHA | Feature | Warm AIHA | Cold Agglutinin Disease | |---------|-----------|------------------------| | **Antibody type** | IgG (rarely IgM) | IgM (pentameric) | | **Temperature optimum** | 37°C | 4°C | | **RBC morphology** | Spherocytes (antibody coating) | Agglutination, then C3 complement | | **Mechanism** | Opsonization → splenic macrophage removal → membrane loss | Complement activation → intravascular hemolysis | | **DAT result** | IgG positive | C3 positive (IgM may wash off) | **High-Yield:** Spherocytes form because IgG-coated RBCs are **partially phagocytosed** by splenic macrophages, losing membrane surface area. This is **NOT** complement-mediated lysis (which causes fragmentation and schistocytes, not spherocytes). ### Why Other Options Are Correct 1. **Warm AIHA is most common (60–70% of AIHA cases)** and typically responds to corticosteroids as first-line therapy — correct. 2. **Cold agglutinin disease** presents with acrocyanosis, Raynaud phenomenon, and hemoglobinuria in cold exposure — correct. 3. **Evans syndrome** = concurrent AIHA + immune thrombocytopenia (ITP) — correct. ### Clinical Pearl **Complement-mediated hemolysis** (as in CAD) produces **intravascular hemolysis** with hemoglobinuria, elevated LDH, and low haptoglobin. **Antibody-mediated opsonization** (as in warm AIHA) produces **extravascular hemolysis** in the spleen with spherocytes and jaundice.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.